192 related articles for article (PubMed ID: 24434586)
1. MRM validation of targeted nonglycosylated peptides from N-glycoprotein biomarkers using direct trypsin digestion of undepleted human plasma.
Lee JY; Kim JY; Cheon MH; Park GW; Ahn YH; Moon MH; Yoo JS
J Proteomics; 2014 Feb; 98():206-17. PubMed ID: 24434586
[TBL] [Abstract][Full Text] [Related]
2. Targeted mass spectrometric approach for biomarker discovery and validation with nonglycosylated tryptic peptides from N-linked glycoproteins in human plasma.
Lee JY; Kim JY; Park GW; Cheon MH; Kwon KH; Ahn YH; Moon MH; Lee HJ; Paik YK; Yoo JS
Mol Cell Proteomics; 2011 Dec; 10(12):M111.009290. PubMed ID: 21940909
[TBL] [Abstract][Full Text] [Related]
3. Development of glycoprotein capture-based label-free method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma.
Chen R; Tan Y; Wang M; Wang F; Yao Z; Dong L; Ye M; Wang H; Zou H
Mol Cell Proteomics; 2011 Jul; 10(7):M110.006445. PubMed ID: 21474793
[TBL] [Abstract][Full Text] [Related]
4. A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasma.
Ahn YH; Shin PM; Oh NR; Park GW; Kim H; Yoo JS
J Proteomics; 2012 Sep; 75(17):5507-15. PubMed ID: 22789673
[TBL] [Abstract][Full Text] [Related]
5. Differential proteomic approach for identification and verification of aberrantly glycosylated proteins in adenocarcinoma lung cancer (ADLC) plasmas by lectin-capturing and targeted mass spectrometry.
Ahn YH; Ji ES; Oh NR; Kim YS; Ko JH; Yoo JS
J Proteomics; 2014 Jun; 106():221-9. PubMed ID: 24780727
[TBL] [Abstract][Full Text] [Related]
6. Monitoring Both Extended and Tryptic Forms of Stable Isotope-Labeled Standard Peptides Provides an Internal Quality Control of Proteolytic Digestion in Targeted Mass Spectrometry-Based Assays.
Lundeen RA; Kennedy JJ; Murillo OD; Ivey RG; Zhao L; Schoenherr RM; Hoofnagle AN; Wang P; Whiteaker JR; Paulovich AG
Mol Cell Proteomics; 2023 Sep; 22(9):100621. PubMed ID: 37478973
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometry analysis of glycoprotein biomarkers in human blood of hepatocellular carcinoma.
Kim KH; Kim JY; Yoo JS
Expert Rev Proteomics; 2019 Jul; 16(7):553-568. PubMed ID: 31145639
[No Abstract] [Full Text] [Related]
8. Combination of improved (18)O incorporation and multiple reaction monitoring: a universal strategy for absolute quantitative verification of serum candidate biomarkers of liver cancer.
Zhao Y; Jia W; Sun W; Jin W; Guo L; Wei J; Ying W; Zhang Y; Xie Y; Jiang Y; He F; Qian X
J Proteome Res; 2010 Jun; 9(6):3319-27. PubMed ID: 20420461
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of aberrant protein glycosylation in liver cancer plasma by AAL-enrichment and MRM mass spectrometry.
Ahn YH; Shin PM; Kim YS; Oh NR; Ji ES; Kim KH; Lee YJ; Kim SH; Yoo JS
Analyst; 2013 Nov; 138(21):6454-62. PubMed ID: 24027776
[TBL] [Abstract][Full Text] [Related]
10. Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides with N-linked glycosylation sites.
Alvarez-Manilla G; Atwood J; Guo Y; Warren NL; Orlando R; Pierce M
J Proteome Res; 2006 Mar; 5(3):701-8. PubMed ID: 16512686
[TBL] [Abstract][Full Text] [Related]
11. Straightforward and Highly Efficient Strategy for Hepatocellular Carcinoma Glycoprotein Biomarker Discovery Using a Nonglycopeptide-Based Mass Spectrometry Pipeline.
Cao WQ; Jiang BY; Huang JM; Zhang L; Liu MQ; Yao J; Wu MX; Zhang LJ; Kong SY; Wang Y; Yang PY
Anal Chem; 2019 Oct; 91(19):12435-12443. PubMed ID: 31453685
[TBL] [Abstract][Full Text] [Related]
12. Multiple Reaction Monitoring for the Quantitation of Serum Protein Glycosylation Profiles: Application to Ovarian Cancer.
Miyamoto S; Stroble CD; Taylor S; Hong Q; Lebrilla CB; Leiserowitz GS; Kim K; Ruhaak LR
J Proteome Res; 2018 Jan; 17(1):222-233. PubMed ID: 29207246
[TBL] [Abstract][Full Text] [Related]
13. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma.
Kuzyk MA; Smith D; Yang J; Cross TJ; Jackson AM; Hardie DB; Anderson NL; Borchers CH
Mol Cell Proteomics; 2009 Aug; 8(8):1860-77. PubMed ID: 19411661
[TBL] [Abstract][Full Text] [Related]
14. Clinical Assay for AFP-L3 by Using Multiple Reaction Monitoring-Mass Spectrometry for Diagnosing Hepatocellular Carcinoma.
Kim H; Sohn A; Yeo I; Yu SJ; Yoon JH; Kim Y
Clin Chem; 2018 Aug; 64(8):1230-1238. PubMed ID: 29875214
[TBL] [Abstract][Full Text] [Related]
15. Multiplexed MRM-based quantitation of candidate cancer biomarker proteins in undepleted and non-enriched human plasma.
Percy AJ; Chambers AG; Yang J; Borchers CH
Proteomics; 2013 Jul; 13(14):2202-15. PubMed ID: 23592487
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry.
Zeng X; Hood BL; Sun M; Conrads TP; Day RS; Weissfeld JL; Siegfried JM; Bigbee WL
J Proteome Res; 2010 Dec; 9(12):6440-9. PubMed ID: 20931982
[TBL] [Abstract][Full Text] [Related]
17. A lectin-coupled, multiple reaction monitoring based quantitative analysis of human plasma glycoproteins by mass spectrometry.
Ahn YH; Shin PM; Ji ES; Kim H; Yoo JS
Anal Bioanal Chem; 2012 Feb; 402(6):2101-12. PubMed ID: 22290386
[TBL] [Abstract][Full Text] [Related]
18. Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma.
Abbatiello SE; Schilling B; Mani DR; Zimmerman LJ; Hall SC; MacLean B; Albertolle M; Allen S; Burgess M; Cusack MP; Gosh M; Hedrick V; Held JM; Inerowicz HD; Jackson A; Keshishian H; Kinsinger CR; Lyssand J; Makowski L; Mesri M; Rodriguez H; Rudnick P; Sadowski P; Sedransk N; Shaddox K; Skates SJ; Kuhn E; Smith D; Whiteaker JR; Whitwell C; Zhang S; Borchers CH; Fisher SJ; Gibson BW; Liebler DC; MacCoss MJ; Neubert TA; Paulovich AG; Regnier FE; Tempst P; Carr SA
Mol Cell Proteomics; 2015 Sep; 14(9):2357-74. PubMed ID: 25693799
[TBL] [Abstract][Full Text] [Related]
19. Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring.
Kim H; Kim K; Yu SJ; Jang ES; Yu J; Cho G; Yoon JH; Kim Y
PLoS One; 2013; 8(5):e63468. PubMed ID: 23717429
[TBL] [Abstract][Full Text] [Related]
20. Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach.
Awan FM; Naz A; Obaid A; Ali A; Ahmad J; Anjum S; Janjua HA
PLoS One; 2015; 10(9):e0138913. PubMed ID: 26414287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
